Cancer cachexia: an orphan with a future
- PMID: 30920780
- PMCID: PMC6438338
- DOI: 10.1002/jcsm.12401
Cancer cachexia: an orphan with a future
Erratum in
-
Corrigendum.J Cachexia Sarcopenia Muscle. 2020 Aug;11(4):1158. doi: 10.1002/jcsm.12605. J Cachexia Sarcopenia Muscle. 2020. PMID: 32808742 Free PMC article. No abstract available.
Keywords: Cancer cachexia; Orphan Disease; Prevalence; Regulatory Pathway.
Conflict of interest statement
ML reports owning shares of Actimed Therapeutics.
Figures
Comment on
-
Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review.J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):22-34. doi: 10.1002/jcsm.12402. J Cachexia Sarcopenia Muscle. 2019. PMID: 30920776 Free PMC article.
References
-
- Lainscak M, Filippatos GS, Gheorghiade M, Fonarow GC, Anker SD. Cachexia: common, deadly, with an urgent need for precise definition and new therapies. Am J Cardiol 2008;101:8E–10E. - PubMed
-
- Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr 2008;27:793–799. - PubMed
-
- Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011;12:489–495. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
